524238 GUJINJEC

Gujarat Inject (Kerala) Share Price

 

 

Start SIP in GUJINJEC

Start SIP

Performance

  • Low
  • ₹64
  • High
  • ₹65
  • 52 Week Low
  • ₹17
  • 52 Week High
  • ₹65
  • Open Price₹65
  • Previous Close₹63
  • Volume43,360
  • 50 DMA₹46.84
  • 100 DMA₹38.95
  • 200 DMA₹32.01

Investment Returns

  • Over 1 Month + 52.42%
  • Over 3 Month + 135.27%
  • Over 6 Month + 196.45%
  • Over 1 Year + 125.18%

Smart Investing Starts Here Start SIP with Gujarat Inject (Kerala) for Steady Growth!

Invest Now

Gujarat Inject (Kerala) Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 368.8
  • PEG Ratio
  • -5
  • Market Cap Cr
  • 93
  • P/B Ratio
  • 9.1
  • Average True Range
  • 1.32
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 5.13
  • RSI
  • 98.03
  • MFI
  • 90.73

Gujarat Inject (Kerala) Financials

Gujarat Inject (Kerala) Technicals

EMA & SMA

Current Price
₹63.50
+ 0.26 (0.41%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹55.71
  • 50 Day
  • ₹46.84
  • 100 Day
  • ₹38.95
  • 200 Day
  • ₹32.01

Resistance and Support

63.83 Pivot Speed
  • R3 65.17
  • R2 64.83
  • R1 64.17
  • S1 63.17
  • S2 62.83
  • S3 62.17

Gujarat Inject (Kerala) Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-14 Quarterly Results
2025-11-13 Quarterly Results
2025-08-14 Quarterly Results
2025-05-20 Audited Results
2025-02-18 Stock Split

Gujarat Inject (Kerala) F&O

Gujarat Inject (Kerala) Shareholding Pattern

0%
90.02%
9.98%

Gujarat Inject (Kerala) FAQs

Gujarat Inject (Kerala) share price is ₹63 As on 25 February, 2026 | 05:55

The Market Cap of Gujarat Inject (Kerala) is ₹93 Cr As on 25 February, 2026 | 05:55

The P/E ratio of Gujarat Inject (Kerala) is 368.8 As on 25 February, 2026 | 05:55

The PB ratio of Gujarat Inject (Kerala) is 9.1 As on 25 February, 2026 | 05:55

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23